The use of nanotechnology in cardiovascular disease
Cardiovascular diseases claim a number of lives globally; many of which are preventable.
With the increase in diets that consist of high saturated fat, salt, and sugar, people often …
With the increase in diets that consist of high saturated fat, salt, and sugar, people often …
Nanomedicine applied to cardiovascular diseases: latest developments
VM Martín Giménez, DE Kassuha… - Therapeutic …, 2017 - journals.sagepub.com
Cardiovascular diseases are a major cause of disability and they are currently responsible
for a significant number of deaths in a large percentage of the world population. A large …
for a significant number of deaths in a large percentage of the world population. A large …
Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases
T Li, W Liang, X Xiao, Y Qian - International journal of …, 2018 - Taylor & Francis
Cardiovascular diseases (CVDs) are one of the most important causes of mortality and
affecting the health status of patients. At the same time, CVDs cause a huge health and …
affecting the health status of patients. At the same time, CVDs cause a huge health and …
Nanotechnology applications for cardiovascular disease treatment: Current and future perspectives
DK Wang, M Rahimi, CS Filgueira - … : nanotechnology, biology and …, 2021 - Elsevier
A large majority of cardiovascular nanomedicine research has focused on fabricating
designer nanoparticles for improved targeting as a means to overcome biological barriers …
designer nanoparticles for improved targeting as a means to overcome biological barriers …
Nanomaterials: a promising therapeutic approach for cardiovascular diseases
Cardiovascular diseases (CVDs) are a primary cause of death globally. A few classic and
hybrid treatments exist to treat CVDs. However, they lack in both safety and effectiveness …
hybrid treatments exist to treat CVDs. However, they lack in both safety and effectiveness …
Nanomedicine approaches for advanced diagnosis and treatment of atherosclerosis and related ischemic diseases
B Hu, KO Boakye‐Yiadom, W Yu… - Advanced …, 2020 - Wiley Online Library
Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …
response to this and other worldwide health epidemics, nanomedicine has emerged as a …
Recent developments in nanomaterials-based drug delivery and upgrading treatment of cardiovascular diseases
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality
worldwide. However, despite the recent developments in the management of CVDs, the …
worldwide. However, despite the recent developments in the management of CVDs, the …
Recent Advancement in Nanotechnology based Drug Delivery for the Management of Cardiovascular disease.
Cardiovascular diseases (CVDs) constitute a predominant cause of both global mortality
and morbidity. To address the challenges in the early diagnosis and management of CVDs …
and morbidity. To address the challenges in the early diagnosis and management of CVDs …
[HTML][HTML] Nanomedicine in coronary artery disease
Nanomedicine is one of the most promising therapeutic modalities researchers are working
on. It involves development of drugs and devices that work at the nanoscale (10–9 m) …
on. It involves development of drugs and devices that work at the nanoscale (10–9 m) …
Bioactive compounds and nanodelivery perspectives for treatment of cardiovascular diseases
Bioactive compounds are comprised of small quantities of extra nutritional constituents
providing both health benefits and enhanced nutritional value, based on their ability to …
providing both health benefits and enhanced nutritional value, based on their ability to …
相关搜索
- disease treatment nanotechnology applications
- upgrading treatment cardiovascular diseases
- promising prospects cardiovascular diseases
- drugs and devices cardiovascular diseases
- application of nanomaterials cardiovascular diseases
- latest developments cardiovascular diseases
- bioactive compounds cardiovascular diseases
- drug delivery cardiovascular diseases